Mass General Brigham, Inc
- SEC CIK
- 0001678378
- Latest filing
- Aug 7, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 7, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 6
- 0 vs. Q1 2026
- Portfolio value
- $361.1M
- −$107.8M (−23.0%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares Tr464288257 | MSCI ACWI ETF | 1,259,657 | $197.7M | 54.8% | −893,820−41.5% | Reduced | – |
| KRMNKarman Holdings Inc. | COMMON STOCK | 1,562,054 | $78.0M | 21.6% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 344,091 | $64.4M | 17.8% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 354,192 | $11.1M | 3.1% | 00.0% | Unchanged | History |
| MAZEMaze Therapeutics, Inc. | COM | 239,994 | $7.16M | 2.0% | 00.0% | Unchanged | History |
| MDLNMedline Inc. | COM CL A | 68,413 | $2.70M | 0.7% | −1,944−2.8% | Reduced | History |